Comparative studies of various antiemetic regimens

Supportive Care in Cancer

Volumn 4, Issue 4, 1996, Pages 270-280

  Roila, Fausto ^a   Tonato, Maurizio ^a   Ballatori, Enzo ^b   Del Favero, Albano ^c  

^a Policlinico Hospital   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

Author keywords

5 HT3receptor antagonists; Antiemetics; Cisplatin; Dexamethasone; Moderately emetogenic chemotherapy

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT;

CLINICAL TRIAL; COMPARATIVE STUDY; HUMAN; NEOPLASM; REVIEW; TREATMENT OUTCOME; VOMITING;

ANTIEMETICS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; HUMANS; NEOPLASMS; TREATMENT OUTCOME; VOMITING;

EID: 0030187153     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf01358879     Document Type: Article

References (57)

1. Andrews PL, Bhandari P, Davey PT, et al (1992) Are all 5-HT3 receptor antagonists the same? Eur J Cancer 28A [Suppl 1]:2-6
2. Basurto C, Roila F, Bracarda S, et al (1988) A double-blind trial comparing antiemetic efficacy and toxicity of metoclopramide vs methylprednisolone vs domperidone in patients receiving doxorubicin chemotherapy alone or in combination with other antiblastic agents. Am J Clin Oncol 11:594-596
3. Beck TM, Hesketh PJ, Madajewicz S, et al (1992) Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting. J Clin Oncol 10:1969-1975
4. Beck TM, Ciociola AA, Jones SE, et al (1993) Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy. Ann Intern Med 118:407-413
5. Bonneterre J, Chevallier B, Metz R, et al (1990) A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil and doxorubicin or epirubicin chemotherapy. J Clin Oncol 8:1063-1069
6. Bonneterre J, Hecquet B, on behalf of the French Northern Oncology Group (1993) Granisetron i.v. compared with ondansetron i.v. plus tablets in the prevention of nausea and vomiting induced by a moderately emetogenic chemotherapy regimen: a randomized cross-over study. In: Satellite Symposium to the 7th European Conference of Clinical Oncology and Cancer Nursing, Jerusalem, Israel, November 1993 (abstract book). Adelphi Communication, Macclesfield, UK, pp 22-24
7. Campora E, Simoni C, Rosso R (1994) Tropisetron versus ondansetron nella prevenzione e controllo dell'emesi in pazienti sottoposte a chemioterapia con FAC/FEC per carcinoma mammario metastatico o operato. Minerva Med 85:25-31
8. Chiara S, Campora E, Lionetto R, et al (1987) Methylprednisolone for the control of CMF-induced emesis. Am J Clin Oncol 10:264-267
9. Del Favero A, Roila F, Tonato M (1993) Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilities. Drug Safety 9:410-428
10. Dicato M (1991) Oral treatment with ondansetron in an outpatient setting Eur J Cancer 27 [Suppl 1]:518-519
11. Fraschini G, Ciociola A, Esparza L, et al (1991) Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy. J Clin Oncol 9:1268-1274
12. Gebbia V, Cannata G, Testa A, et al (1994) Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Cancer 74:1945-1952
13. Gralla RJ, Itri LM, Pisko SE, et al (1981) Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 305:905-909
14. Hacking A, on behalf of the Granisetron Study Group (1992) Oral granisetron-simple and effective: a preliminary report. Eur J Cancer 28A [Suppl 1]: S28-S32
15. Heron JF, Goedhals L, Jordan JP, et al (1994) Oral granisetron alone and in combination with dexamethasone: a double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis. Ann Oncol 5:579-584
16. Hesketh PJ, Harvey WH, Harker WG, et al (1994) A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis. J Clin Oncol 12:596-600
17. Hulstaert F, Van Belle S, Bleiberg H, et al (1994) Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomiting. J Clin Oncol 12:2439-2446
18. Italian Group for Antiemetic Research (1992) Ondansetron + dexamethasone versus metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Lancet 340:96-99
19. Italian Group for Antiemetic Research (1993) Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. J Clin Oncol 11:2396-2404
20. Jantunen IT, Kataja VV, Johansson RT (1992) Ondansetron and tropisetron with dexamethasone in the prophylaxis of acute vomiting induced by non-cisplatin-containing chemotherapy. Acta Oncol 31:573-575
21. 3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy - a randomised study. Eur J Cancer29A:1669-1672
22. Johnsonbaugh RE, Mason BA, Friedman CJ, et al (1994) Oral granisetron is an effective anti-emetic in patients receiving moderately emetogenic chemotherapy. Proc Am Soc Clin Oncol Annu Meet 13:437
23. Jones AL, Hill AS, Soukop M, et al (1991) Comparison of dexamethasone in the prophylaxis of emesis induced by moderately emetogenic chemotherapy. Lancet 338:483-187
24. Joss RA, Bacchi M, Buser K, et al (1994) Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients. Ann Oncol 5:253-258
25. Kaasa S, Kvaloy S, Dicato MA, et al (1990) A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: a randomized, double-blind study. Eur J Cancer 26:311-314
26. Kaizer L, Warr D, Hoskins P, et al (1994) Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a phase III trial by the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 12:1050-1057
27. Latreille J, Stewart D, Laberge F, et al (1993) Dexamethasone (DEX) improves the efficacy of granisetron (GRAN) in the first 24 hours following high dose cisplatin (HDCP) chemotherapy. Eur J Cancer 29A [Suppl 6]: S 208
28. 3 receptor antagonists in the prophylaxis of acute vomiting induced by highly emetogenic chemotherapy (high-dose cisplatin) for treatment of primary head and neck cancer. Proc Am Soc Clin Oncol Annu Meet 13:428
29. Markman M, Sheidler V, Ettinger DS, et al (1984) Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy. N Engl J Med 311:549-552
30. Marschner NW, Adler M, Nagel GA, et al (1991) Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide. Eur J Cancer 27:1137-1140
31. Martoni A, Angelelli B, Guaraldi E, et al (1994) Granisetron versus ondansetron in the prevention of cisplatin-induced emesis. An open randomised cross-over study. Proc Am Soc Clin Oncol Annu Meet 13:431
32. Marty M, d'Allens H, Groupe Multicentrique Français (1990) Etude randomisée en double-insu comparant l'efficacité de l'ondansetron selon deux modes d'administration: injection unique et perfusion continue. Cah Cancer 2:541-546
33. Marty M, Granisetron Study Group (1990) A comparative study of the use of granisetron, a selective 5-HT3 antagonist, versus a standard antiemetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. Eur J Cancer 26 [Suppl 1]:28-32
34. Marty M, Kleisbauer J-P, Fournel P, et al (1995) Is Navoban (tropisetron) as effective as Zofran (ondansetron) in cisplatin-induced emesis? Anti-Cancer Drugs 6:15-21
35. 3 receptors. Ann Oncol 5 [Suppl 8]:204
36. Navari RM, Kaplan HG, Gralla RJ, et al (1994) Efficacy and safety of granisetron, a selective 5-hydroxytryptamine-3 receptor antagonist, in the prevention of nausea and vomitins induced by high-dose cisplatin. J Clin Oncol 12:2204-2210
37. Navari R, Hesketh P, Grote T, et al (1995) A double-blind, randomized, comparative i.v. study of single dose dolasetron vs ondansetron in preventing cisplatin-related emesis. Proc Am Soc Clin Oncol Annu Meet 14:522
38. Navari R, Hesketh P, Hall S, et al, on behalf of the Granisetron Study Group (1995) Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. J Clin Oncol 13:1242-1248
39. Noble A, Bremer K, Goedhals L, et al (1994) A double-blind, randomised, crossover comparison of granisetron and ondansetron in 5-day fractionated chemotherapy: assessment of efficacy, safety and patient preference. Éur J Cancer 30A:1083-1088
40. Perez EA (1994) Acute emesis: can oral treatment match i.v.? Extended abstracts of the Satellite Symposium "Emesis control and beyond", 19th ESMO Congress, Lisbon, 1994, pp 18-25
41. Pollera CF, Nardi M, Marolla P, et al (1989) Effective control of CMF-related emesis with high-dose dexamethasone: results of a double-blind, crossover trial with metoclopramide and placebo. Am J Clin Oncol 12:524-529
42. Riviere A, on behalf of the Granisetron Study Group (1994) Dose finding study of granisetron in patients receiving high-dose cisplatin chemotherapy. Br J Cancer 69:967-971
43. Roila F, Basurto C, Minotti V, et al (1988) Methylprednisolone vs metoclopramide for prevention of nausea and vomiting in breast cancer patients treated with intravenous cyclophosphamide, methotrexate, 5-fluorouracil: a double-blind randomized study. Oncology 45:346-349
44. Roila F, Tonato M, Basurto C, et al (1989) Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research. J Clin Oncol 7:1693-1700
45. Roila F, Tonato M, Cognetti F, et al (1991) Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol 9:675-678
46. Roila F, De Angelis V, Cognetti F, et al (1995) Ondansetron vs granisetron, both combined with dexamethasone in the prevention of cisplatin-induced emesis. Proc Am Soc Clin Oncol Annu Meet 14:523
47. Ruff P, Paska W, Goedhals L, et al, on behalf of the Ondansetron and Granisetron Emesis Study Group (1994) Ondansetron compared with granisetron in the prophylaxis of cisplatin-induced acute emesis: a multicentre double-blind, randomised, parallel group study. Oncology 51:113-118
48. Schmidt M, Sorbe B, Hogberg T, et al (1993) Efficacy and tolerability of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin. Ann Oncol 4 [Suppl 3]:31-34
49. Seynaeve C, Schuller J, Buser K, et al (1992) Comparison of the antiemetic efficacy of different doses of ondansetron given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study. Br J Cancer 66:192-197
50. Smith DB, Newlands ES, Rustin GJS, et al (1991) Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet 338:487-490
51. Smyth JF, Coleman RE, Nicolson M, et al (1991) Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron? Br Med J 303:1423-1426
52. Soukop M, on behalf of the Granisetron Study Group (1994) A dose-finding study of granisetron, a novel antiemetic, in patients receiving high-dose cisplatin. Support Care Cancer 2:177-183
53. Stewart A, McQuade B, Cronje JDE, et al (1995) Ondansetron compared with granisetron in the prophylaxis of cyclophosphamide-induced emesis in out-patients: a multicentre, double-blind, double-dummy, randomised, parallel-sroup study. Oncology 52:202-210
54. The Italian Group for Antiemetic Research (1995) Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. N Engl J Med 332:1-5
55. The Italian Group for Antiemetic Research (1995) Persistence of efficacy of three antiemetic regimens and prognostic factors in patients undergoing moderately emetogenic chemotherapy. J Clin Oncol 13:2417-2426
56. Van Belle SJP, Stamatakis L, Bleiberg H, et al (1994) Dose-finding study of tropisetron in cisplatin-induced nausea and vomiting. Ann Oncol 5:821-825
57. Warr D, Willan A, Fine S, et al (1991) Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy-induced emesis. J Natl Cancer Inst 83:1169-1173